Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients with Ankylosing spondylitis more frequently discontinue work. This study measures the impact of Enbrel on work participation.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Etanercept

Criteria

Inclusion Criteria:

• Active AS patients (as judged by the treating MD) who are currently employed.

• Patients who are scheduled by their rheumatologist to initiate treatment with Etanercept.

Exclusion Criteria:

• Patients who initiated a procedure for eligibility of work disability/pension.

• Patients with previous use of TNF-alpha inhibitors either in commercial use, or in a study for the treatment of AS or a related spondylarthropathy condition.